DK2083016T3 - Bakterielle superantigenvacciner - Google Patents

Bakterielle superantigenvacciner

Info

Publication number: DK2083016T3
Authority: DK; Denmark
Prior art keywords: superantigen; spea; altered; vaccines; attenuated
Prior art date: 2001-11-26

Application number

DK09001558.7T

Other languages

English (en)

Inventor

Robert G Ulrich

Original Assignee

U S Medical Res Inst Of Infectious Diseases

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-26

Filing date

2001-11-26

Publication date

2011-10-03

2001-11-26 Application filed by U S Medical Res Inst Of Infectious Diseases filed Critical U S Medical Res Inst Of Infectious Diseases

2011-10-03 Application granted granted Critical

2011-10-03 Publication of DK2083016T3 publication Critical patent/DK2083016T3/da

Links

101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 title abstract 6
231100000617 superantigen Toxicity 0.000 title abstract 6
229960005486 vaccine Drugs 0.000 title abstract 2
230000001580 bacterial effect Effects 0.000 title 1
231100000765 toxin Toxicity 0.000 abstract 4
239000003053 toxin Substances 0.000 abstract 4
108700012359 toxins Proteins 0.000 abstract 4
241001415395 Spea Species 0.000 abstract 3
230000002238 attenuated effect Effects 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK09001558.7T 2001-11-26 2001-11-26 Bakterielle superantigenvacciner DK2083016T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/US2001/046540 WO2003056015A1 (en)	2001-11-26	2001-11-26	Bacterial superantigen vaccines
EP01996119A EP1461433A1 (en)	2001-11-26	2001-11-26	Bacterial superantigen vaccines

Publications (1)

Publication Number	Publication Date
DK2083016T3 true DK2083016T3 (da)	2011-10-03

Family

ID=21743073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09001558.7T DK2083016T3 (da)	2001-11-26	2001-11-26	Bakterielle superantigenvacciner

Country Status (6)

Country	Link
EP (2)	EP2083016B1 (da)
AT (1)	ATE512978T1 (da)
AU (1)	AU2002227232A1 (da)
CA (1)	CA2506538C (da)
DK (1)	DK2083016T3 (da)
WO (1)	WO2003056015A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7087235B2 (en) *	1997-06-25	2006-08-08	The United States Of America As Represented By The Secretary Of The Army	Fusion protein of streptococcal pyrogenic exotoxins
WO2019023341A1 (en)	2017-07-27	2019-01-31	Integrated Biotherapeutics, Inc.	IMMUNOGENIC COMPOSITION COMPRISING A MELTING PEPTIDE DERIVED FROM TOXOIDS OF SUPERANTIGENES
WO2022128243A1 (en) *	2020-12-18	2022-06-23	Biomedizinische Forschung & Bio-Produkte AG	Protective staphylococcal exotoxin vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6555494A (en) *	1993-04-05	1994-10-24	National Jewish Center For Immunology And Respiratory Medicine	Method for treating kawasaki syndrome via immune modulation
WO1996014744A1 (en) *	1994-11-14	1996-05-23	National Jewish Center For Immunology And Respiratory Medicine	Protective effects of mutated superantigens
BR9714641A (pt) *	1996-12-06	2002-01-22	Univ Minnesota	Mutantes de toxina a de estreptococo e métodos de uso
CA2338184A1 (en) *	1998-08-13	2000-02-24	Walter Reed Army Institute Of Research	Bacterial superantigen vaccines

2001
- 2001-11-26 EP EP09001558A patent/EP2083016B1/en not_active Expired - Lifetime
- 2001-11-26 AU AU2002227232A patent/AU2002227232A1/en not_active Abandoned
- 2001-11-26 WO PCT/US2001/046540 patent/WO2003056015A1/en not_active Ceased
- 2001-11-26 DK DK09001558.7T patent/DK2083016T3/da active
- 2001-11-26 AT AT09001558T patent/ATE512978T1/de not_active IP Right Cessation
- 2001-11-26 CA CA2506538A patent/CA2506538C/en not_active Expired - Fee Related
- 2001-11-26 EP EP01996119A patent/EP1461433A1/en not_active Ceased

Also Published As

Publication number	Publication date
CA2506538A1 (en)	2003-07-10
ATE512978T1 (de)	2011-07-15
EP1461433A1 (en)	2004-09-29
EP2083016B1 (en)	2011-06-15
AU2002227232A1 (en)	2003-07-15
EP2083016A1 (en)	2009-07-29
CA2506538C (en)	2013-07-09
WO2003056015A1 (en)	2003-07-10

Similar Documents

Publication	Publication Date	Title
DE602004024542D1 (de)	2010-01-21	Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DE602004020189D1 (de)	2009-05-07	Adjuvante influenza-vakzine
DK1545597T3 (da)	2011-01-31	Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons
ATE405647T1 (de)	2008-09-15	Rekombinantes gelatin in impstoffen
ATE443768T1 (de)	2009-10-15	Impfstoff gegen staphylokokken-vergiftung
ATE501726T1 (de)	2011-04-15	Zusammensetzung mit immunogenen mikroteilchen
AU3942202A (en)	2002-06-11	Transgenic transchromosomal rodents for making human antibodies
ATE449840T1 (de)	2009-12-15	Alpha-amylasevariante mit veränderten eigenschaften
TR200704553T2 (tr)	2007-11-21	Streptokok antijenleri.
AU2003244855A1 (en)	2004-01-23	Method to enhance an immune response of nucleic acid vaccination
DE69713408D1 (de)	2002-07-25	Streptococcus equi Impstoff
DK1212422T3 (da)	2007-07-02	Humane CTLA-4-antistoffer og anvendelserne deraf
ATE542829T1 (de)	2012-02-15	Impfstoff
DK1007624T3 (da)	2004-02-23	DS11 (KCTC 0231BP), ny bakterie sp.-stamme og ny phytase, der er produceret af denne
ATE426026T1 (de)	2009-04-15	Chimare arterivirus-ahnliche partikel
BR0200852A (pt)	2003-03-25	Sistema de câmara de combustão
DE60130998D1 (de)	2007-11-29	Ribavirin-enthaltende vakzine
ATE512978T1 (de)	2011-07-15	Bakterielle superantigenimpfstoffe
DE69610106D1 (de)	2000-10-05	Toxine und toxoide von clostridium difficile als schleimhautadjuvans
ATE453714T1 (de)	2010-01-15	Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
WO2006123155A3 (en)	2007-07-19	Vaccine composition comprising b-subunit of e. coli heat toxin and an atigen and an adjuvant
ATE484744T1 (de)	2010-10-15	Impfstoffe die gegen streptococcus pneumonia infektionen schützen.
DK0946730T3 (da)	2006-07-10	Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse
AU2003217730A1 (en)	2003-09-09	Modification of bioassays for detection of antigen characteristic of bacteria that are causative of ear and respiratory infections in children
NO20041564L (no)	2004-04-16	Infeksios lakse anemi-virus vaksine